Adverum Biotechnologies Inc (NASDAQ:ADVM)

1.08
Delayed Data
As of Jun 24
 0.00 / 0.00%
Today’s Change
0.80
Today|||52-Week Range
3.86
-38.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-47.5M-113.7M-56.1M-72.6M
 
 
 
 
 
Depreciation812.0K1.6M2.1M1.8M
 
 
 
 
 
Total Other Cash Flow12.5M72.1M9.4M18.5M
 
 
 
 
 
Funds From Operations-34.1M-40.0M-44.7M-53.6M
 
 
 
 
 
Funds From/For Other Operating Expenses1.2M-1.6M756.0K371.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-35.3M-38.4M-45.4M-54.0M
 
 
 
 
 
 
InvestingIncrease In Investments-88.4M0.00-209.8M-78.7M
 
 
 
 
Decrease In Investments49.9M37.7M88.6M149.0M
 
 
 
 
 
Capital Expenditures-3.0M-2.4M-1.0M-809.0K
 
 
 
 
 
Fixed Asset Disposal--3.4M0.00--
 
 
Net Cash Flow Investing-41.6M38.8M-122.2M69.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--0.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.00-175.0K
 
 
Net Proceeds Stock Sale139.3M949.0K17.1M71.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.00--0.000.00--
Cash Dividends Paid - Total0.00--0.000.00--
Other Sources - Financing--100.0K0.00100.0K
 
 
 
Other Uses - Financing427.0K493.0K313.0K1.2M
 
 
 
 
 
Net Cash Flow - Financing138.9M556.0K16.7M69.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-9.0K-143.0K-774.0K0.00
 
 
 
 
 
Net Change In Cash62.0M965.0K-150.9M85.4M